John McGuire
Survivor
Elizabeth Jenkins
Board Chair, DCC
Nat Moore
Miami Dolphins Alumni
Dr. Sophia George
Physician
Vaughn Edelson
DCC Participant
Lisa Siegel
DCC Participant
Oscar Ortiz
DCC Participant
Mari Campuzano
DCC Participant
Eddie Nurquez
Cancer Survivor
Gisenia Reyes
Cancer Survivor
Andrew Davis
Cancer Survivor
Janine Stanwood
Cancer Survivor
Elysa Merlin
Cancer Survivor
David D’Eugenio
Cancer Survivor
Dr. Erin Kobetz
Cancer Survivor
Principal Investigator
Sonia Rodriguez
Cancer Survivor
Josh Young
Cancer Survivor
Eileen Youtie
In Memoriam
Marina Makhnach
Cancer Survivor
Daisy Atkins
Cancer Survivor
David Perez
Raquel Kaufler
Cancer Survivor
Faces of the DCC

Over one
Million Miles
Conquered

Play
#1 Team Fundraising Event
in the National Football League
The DCC began 14 years ago with one goal in mind: to unite the community against one of the most insidious diseases of our generation. Today, the DCC is a year-round movement focused on the challenge the cancer community faces every day, reminding us that you don’t have to have cancer to fight cancer.
View message from Tom
Tom Garfinkel,
Vice-Chairman, President
and Chief executive officer
of the Miami Dolphins
Stephen D. Nimer, M.D.
Sylvester Comprehensive Cancer Center
For the Sylvester Comprehensive Cancer Center, the DCC has played a crucial role in advancing our drive towards more cures. We are proud to present you with the, Faces of the DCC, a project dedicated to documenting the impact from this incredible partnership.
View message from Dr. Nimer
Dr. Stephen D. Nimer, M.D.
Sylvester Comprehensive Cancer Center

Eleven Record
breaking
eventsScroll Down

2010

DCC I

Total Funds Raised: $533,106

Number of Participants: 411

LEARN MORE

2011

DCC II

Total Funds Raised: $1,070,000

Number of Participants: 1,020

LEARN MORE

2012

DCC III

Total Funds Raised: $2,200,000

Number of Participants: 2,542

LEARN MORE

2013

DCC IV

Total Funds Raised: $3,100,000

Number of Participants: 2,750

LEARN MORE

2015

DCC V

Total Funds Raised: $4,650,000

Number of Participants: 2,912

LEARN MORE

2016

DCC VI

Total Funds Raised: $5,064,381

Number of Participants: 3,466

LEARN MORE

2017

DCC VII

Total Funds Raised: $6,000,157

Number of Participants: 3,487

LEARN MORE

2018

DCC VIII

Total Funds Raised: $5,079,000

Number of Participants: 3,107

LEARN MORE

2019

DCC IX

Total Funds Raised: $5,237,879

Number of Participants: 3,191

LEARN MORE

2020

DCC 10

Total Funds Raised: $6,200,000

Number of Participants: 3,921

LEARN MORE

2021

DCC XI

Total Funds Raised: $6,300,000

Number of Participants: 3,390

LEARN MORE

2022

DCC XII

Total Funds Raised: $8,412,556

Number of Participants: 4,484

LEARN MORE

2023

DCC XIII

Total Funds Raised: $10,548,343

Number of Participants: 5,642

LEARN MORE

Sylvester
by the
numbers

Like any great team, Sylvester's numbers tell our story. Our statistics show the journey of how a cancer center, and its community, worked collectively to achieve the most prestigious title—National Cancer Institute (NCI)-designation—in pursuit of a cure. None of it would have been possible without the DCC, as 100% of participant-raised funds goes directly toward life-saving cancer research at Sylvester.

What NCI-designation means to you.

1st
and only, NCI-designated
Cancer Center in South Florida
2,600+
PHYSICIANS, RESEARCHERS AND STAFF DEDICATED TO CANCER CARE, RESEARCH AND EDUCATION
35,300+
INDIVIDUALS ENROLLED IN CLINICAL STUDIES OVER THE PAST 10 YEARS
2,300+
STEM CELL TRANSPLANTS AND T-CELL THERAPIES COMPLETED
297+
CLINICAL STUDIES UNDERWAY
10
TREATMENT FACILITIES ACROSS SOUTH FLORIDA
13
Cancer support services and 24 cancer support groups
$39MM raised
over 10 years

Funding
Distribution

The bold discoveries at Sylvester Comprehensive Cancer Center that are funded by the Dolphins Challenge Cancer are changing the future of cancer treatment and care for generations to come. Thanks to the overwhelming support of the DCC, Sylvester has established groundbreaking programs with impact in cancer epigenetics, tumor biology, and cancer control. Now more than ever, we are committed to advancing cancer care through breakthrough science, leading-edge technology, and personalized patient care.

The experts who are leading innovative research and delivering excellent care are among the most dedicated, compassionate members of our community. Many participate in the DCC every year in solidarity with patients, friends, and colleagues. Together, we are striding and riding toward a future that is cancer-free.

In our renewed mission to challenge cancer year-round, funding from the DCC will be allocated to support Sylvester’s more than 300 active clinical trials; survivorship programs; seed money to accelerate cutting-edge research; and innovative cancer treatments such as immunotherapy.

Please click on the button below for a full list of physicians, scientists and research areas that have received funding from the DCC throughout the years.

Research Funding List

Faces
of our
corporate
champions

Community partners push the Dolphins Challenge Cancer to new heights each year. Our champions create invaluable impact by integrating the DCC mission at multiple levels throughout their organizations. From holding board positions to striving for 100 percent employee commitment to rallying behind coworkers going through cancer, they exemplify the type of dedication and teamwork that transforms our community.

Jose "Pepe" Dans

Jose "Pepe" Dans joined the Dolphins Cancer Challenge (DCC) after experiencing cancer's devastating impact on his family. "No one is exempt from cancer," said Dans, founder and president of WOW MTKG, a marketing agency in Coral Gables.

Read Story
Marc Cannon

Marc Cannon is the driving force for Team AutoNation's powerful commitment to the Dolphins Cancer Challenge. "Our philanthropic efforts are dedicated to raising money to fight cancer," said Cannon, who is Executive Vice President and Chief Customer Experience Officer of the Fort Lauderdale-based Fortune 500 company.

Read Story
Jennifer Stearns Buttrick

Jennifer Stearns Buttrick was diagnosed with advanced kidney cancer in 2006, just two days after giving birth to her third child. After exploring her options, the Miami attorney turned to Sylvester for leading-edge treatment.

Read Story
Bob Moss

As chairman and founder of Moss Construction, whose portfolio includes a number of University of Miami projects, Moss feels a deep sense of connection to Sylvester Comprehensive Cancer Center.

Read Story
More than
30,000 participants

Community Partnerships

Join us in making an impact